Kimberly A. Spickes, CNP

January 27, 2023

Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.

January 27, 2023

The panel shares the most critical unmet needs for patients with endometrial cancer.

January 20, 2023

Kimberly A. Spickes, CNP, discusses how often patients with endometrial cancer have dose reductions or interruptions at her institution, and who is involved in the decision to dose-reduce.

January 20, 2023

Nurse Practitioner Kimberly Halla explains the proactive measures she takes to ensure patients with endometrial cancer are prepared to experience and manage the adverse effects of treatment.

January 13, 2023

Kimberly A. Spickes, CNP, details the adverse events she sees with combination lenvatinib and pembrolizumab treatment for recurrent endometrial cancer.

January 13, 2023

Kimberly Halla, NP, describes the standards for monitoring patients on therapy for recurrent endometrial cancer, including how often patients are seen in-person.

January 06, 2023

The panel explains how to educate patients on the adverse effects they may experience with chemotherapy, their options for management, and the importance of encouraging patients to contact their care team.

January 06, 2023

The panel reviews the second-line treatment options for patients with recurrent endometrial cancer.

December 22, 2022

Nurse Practitioner Kathleen Lutz talks about the efficacy of chemotherapy in patients with endometrial cancer, and how she discusses the chance of disease recurrence with patients.

December 22, 2022

Continuing her discussion, Kathleen highlights the most common adverse events she sees in patients treated with chemotherapy for advanced endometrial cancer who are unfit for surgery.